U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.858C>A (p.Ser286Arg) AND Cardiovascular phenotype

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002446473.5

Allele description [Variation Report for NM_000527.5(LDLR):c.858C>A (p.Ser286Arg)]

NM_000527.5(LDLR):c.858C>A (p.Ser286Arg)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.858C>A (p.Ser286Arg)
Other names:
NP_000518.1:p.S286R; NM_000527.5(LDLR):c.858C>A
HGVS:
  • NC_000019.10:g.11107432C>A
  • NG_009060.1:g.23052C>A
  • NM_000527.5:c.858C>AMANE SELECT
  • NM_001195798.2:c.858C>A
  • NM_001195799.2:c.735C>A
  • NM_001195800.2:c.354C>A
  • NM_001195803.2:c.477C>A
  • NP_000518.1:p.Ser286Arg
  • NP_000518.1:p.Ser286Arg
  • NP_001182727.1:p.Ser286Arg
  • NP_001182728.1:p.Ser245Arg
  • NP_001182729.1:p.Ser118Arg
  • NP_001182732.1:p.Ser159Arg
  • LRG_274t1:c.858C>A
  • LRG_274:g.23052C>A
  • LRG_274p1:p.Ser286Arg
  • NC_000019.9:g.11218108C>A
  • NM_000527.4:c.858C>A
  • P01130:p.Ser286Arg
  • c.858C>A
Protein change:
S118R
Links:
LDLR-LOVD, British Heart Foundation: LDLR_000129; UniProtKB: P01130#VAR_005351; dbSNP: rs140241383
NCBI 1000 Genomes Browser:
rs140241383
Molecular consequence:
  • NM_000527.5:c.858C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.858C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.735C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.354C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.477C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002681307Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(May 3, 2023)
germlineclinical testing

PubMed (16)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia.

Nauck MS, Köster W, Dörfer K, Eckes J, Scharnagl H, Gierens H, Nissen H, Nauck MA, Wieland H, März W.

Hum Mutat. 2001 Aug;18(2):165-6.

PubMed [citation]
PMID:
11462246

Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Hobbs HH, Brown MS, Goldstein JL.

Hum Mutat. 1992;1(6):445-66. Review.

PubMed [citation]
PMID:
1301956
See all PubMed Citations (16)

Details of each submission

From Ambry Genetics, SCV002681307.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (16)

Description

The p.S286R pathogenic mutation (also known as c.858C>A), located in coding exon 6 of the LDLR gene, results from a C to A substitution at nucleotide position 858. The serine at codon 286 is replaced by arginine, an amino acid with dissimilar properties, and is located in the ligand binding 7 domain. This alteration, also referred to as S265R and FH Greece-2, has been detected in several cohorts and multiple unrelated individuals with hypercholesterolemia from various ethnic backgrounds, and has been reported to result in reduced LDL receptor activity (Hobbs HH et al. Hum. Mutat., 1992;1:445-66; Day IN et al. Hum. Mutat., 1997;10:116-27; Traeger-Synodinos J et al. Hum. Genet., 1998 Mar;102:343-7; Nauck MS et al. Hum. Mutat., 2001 Aug;18:165-6; Mihaylov VA et al. J. Hum. Genet., 2004 Mar;49:173-6; Whittall RA et al. Ann. Clin. Biochem., 2010 Jan;47:44-55; Huijgen R et al. Eur. Heart J., 2012 Sep;33:2325-30; Mollaki V et al. Atherosclerosis, 2014 Dec;237:798-804; Klanar G et al. J. Am. Coll. Cardiol., 2015 Sep;66:1250-1257). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024